Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

German Switch: Azelastine-Fluticasone Nasal Spray Approved On Second Try, Cytisine Rejected Again

Aug 07 2024

• By David Ridley

Rendering of a German flag

Related Content

German Switch Committee Rejects Sildenafil And Tadalafil, Ball Now In Ministry’s Court

Jul 21 2023

Plant-Based Smoking Cessation Alternative Cytisine ‘Likely’ To Help Quitters

Jun 14 2023

Viatris Retains Interest In OTC As It Spies Switch Opportunities

Oct 04 2023

US Smoking Cessation Options Could Expand Behind Achieve Life’s Cytisinicline Studies

Jul 13 2023

Why Did Germany Reject OTC Switch Of Low-Cost Smoking Cessation Drug Cytisine?

Apr 12 2023

Achieve Life Sciences Believes It Has The New Chantix

Sep 28 2023

Additional Topics

Germany Europe Advisory Committees Drug Review Ingredients Innovation Market Access Market Intelligence OTC Drugs Prescription To OTC Switch Regulation Safety Consumer

More from Europe

More from Geography

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window